Innovation
23 patent families (13 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace accelerating. Cited 3,035 times.
| Year | Filings |
|---|---|
| 2014 | 4 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 12 |
| 2025 | 12 |
| 2026 | 5 |
Social engagement
Social engagement: 4.3K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Ysios Capital, Gilde Healthcare.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Private equity | 1 | 11% |
| Other / undisclosed | 1 | 11% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
6 Nov 2025 · Director Small Molecules CMC · Nijmegen, Gelderland
Based on job postings tracked across public sources.
Recent activity
7 May 2026
Event
PEGSBoston
21 Apr 2026
Recognition
17 Apr 2026
Event
ESRR26